Floating Button
Home Capital Broker's Calls

CLSA upgrades Genting Singapore to ‘buy’ amidst healthy recovery

Douglas Toh
Douglas Toh • 2 min read
CLSA upgrades Genting Singapore to ‘buy’ amidst healthy recovery
CLSA upgrades Genting Singapore to ‘buy’ at unchanged target price
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

CLSA analyst Sue Lin Lim has upgraded Genting Singapore (GENS) (SGX:G13) to a “buy” call after Las Vegas Sands (LVS) released its results for the 2QFY2023 ended June. Lim has kept her target price unchanged at $1.26.

“LVS’s earnings call indicated the Singapore gaming industry continued to chart progress towards recovery as visitations improved with increases in flight capacity,” Lim writes in her report dated July 20.

“MBS’s recovery should be a strong read-through for GENS, though it tends to lag that of MBS,” she adds.

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2026 The Edge Publishing Pte Ltd. All rights reserved.